| 摘要 |
PURPOSE: A pharmaceutical formulation containing niflumic acid is provided to improve elution rate inside the body and enhance storage stability. CONSTITUTION: A pharmaceutical formulation having solubilized niflumic acid contains a base selected from polyethylene glycol, propylene glycol, diethyleneglycol monoethylether, glycerin or triacetin and a solubilizing agent selected from ethanolamine, diethanolamine, triethanolamine, sodium lauryl sulfate, or basic amino acid. The pharmaceutical formulation contains polyvinylpyrrolidone. The pharmaceutical formulation is soft capsule or hard capsule.
|
